from FDA,2023.09
Exkivity reduces the growth of non-small cell lung cancer by binding to and inhi···【more】
Release date:2024-08-09Recommended:140
Exkivity works by binding to and blocking EGFR exon 20 insertion mutations, whic···【more】
Release date:2024-08-09Recommended:151
Exkivity was granted accelerated FDA approval in 2021 based on results from the ···【more】
Release date:2024-08-09Recommended:161